Adalimumab in the treatment of rheumatoid arthritis

Author： Voulgari Paraskevi V   Kaltsonoudis Evripidis   Papagoras Charalampos   Drosos Alexandros A  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.12, Iss.12, 2012-12, pp. : 1679-1686

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Etanercept in the treatment of rheumatoid arthritis

By Hunt Laura   Emery Paul  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 10, 2013-10 ,pp. : 1441-1450

Informa Healthcare

Access to resources Recommend Favorite

Adalimumab for the treatment of severe psoriasis and psoriatic arthritis

By Papoutsaki Marina   Costanzo Antonio   Chimenti Maria-Sole   Chimenti Sergio  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 3, 2008-03 ,pp. : 363-370

Informa Healthcare

Access to resources Recommend Favorite

Adalimumab: an anti-TNF agent for the treatment of psoriatic arthritis

By Mease Philip J  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 11, 2005-11 ,pp. : 1491-1504

Informa Healthcare

Access to resources Recommend Favorite

Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis

By Saraceno Rosita  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 9, 2013-09 ,pp. : 1325-1334

Informa Healthcare

Access to resources Recommend Favorite

Cytokine inhibitors in the treatment of rheumatoid arthritis

By Gabay Cem  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 2, 2002-02 ,pp. : 135-149

Informa Healthcare

Access to resources Recommend Favorite